secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001193125-23-205589
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Q2 net loss $5.4M; revenue $1.7M, cash $31.4M; two royalty deals in H1
---------------------------------------------------------------------------

- Total revenue $1.7M (Q2 2022: $1.0M), driven by $1.1M milestone from Janssen license.
- Net loss $5.4M vs $4.7M in Q2 2022; includes $1.6M non-cash impairment on Bioasis royalty.
- Cash and equivalents $31.4M at June 30, 2023, down from $57.8M at Dec 31, 2022.
- Net cash used in operations $7.2M, including $4.1M one-time arbitration settlement cost.
- Expects lower milestone receipts in 2023 due to partner delays; cash sufficient for multiple years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312523205589/0001193125-23-205589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312523205589/d476330d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-205589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer